(Reuters) - Shares of the biotech company jumped almost 15 percent to
$56.98 in morning trade on the Nasdaq. Earlier, they reached a
new year high of $57.45.
Second-quarter revenue, which came solely from Soliris,
soared to $9.8 million from $300,000 reported a year ago.
Read more at Reuters.com Market News
$56.98 in morning trade on the Nasdaq. Earlier, they reached a
new year high of $57.45.
Second-quarter revenue, which came solely from Soliris,
soared to $9.8 million from $300,000 reported a year ago.
Read more at Reuters.com Market News
No comments:
Post a Comment